Skip to main content

Table 3 Cannabis substitution for pharmaceuticals among 275 Michigan medical cannabis patients, influences for substitution, and primary care provider knowledge of substitution

From: Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution

    Influences for substitution (%)
Substance type Use n (%) Substitution (%) Experiences Healthcare provider Dispensary Individuals Other
Amphetamines 52 (19%) 75 89 11 0 3 14
Anticonvulsants 30 (13%) 70 87 22 4 8 4
Antidepressants 141 (51%) 53 93 22 7 6 6
Antiemetics 33, 12% 79 87 13 4 0 4
Antihistamines 94, 34% 36 100 3 0 3 6
Antipsychotics 19 (7%) 78 71 43 0 7 0
Anxiolytics or benzodiazepines 64 (23%) 73 87 34 4 8 8
Muscle relaxers 107 (39%) 82 88 15 3 5 11
Non-opioid pain relievers 93 (34%) 76 97 10 4 6 12
Nonsteroidal anti-inflammatories 125 (46%) 62 92 14 3 4 9
Opioids 102 (37%) 86 88 28 11 9 12
Non-amphetamine stimulants 19 (7%) 50 89 11 0 11 22
Prescription cannabinoids 5 (2%) 75 75 0 0 25 25
Sedatives 34 (12%) 88 93 25 7 4 14
Sleep aids 79 (29%) 83 95 15 6 8 5
Steroids 44 (16%) 64 55 18 2 0 2
  1. N = 275 participants total, 192 of whom reported any substitution. Note: all values are proportions of relevant groups. Use indicates proportion of participants who have used a substance. Substitution indicates proportion of participants using a substance who have reduced or stopped their use because of medical cannabis. Influences for substitution include participant’s own experimentation and experiences, advice from primary health/medical care provider, advice from my medical marijuana caregiver/dispensary, advice from other individual(s), and other source of information
  2. PCP primary care provider
\